ReviewThe Egyptian journal of neurology, psychiatry and neurosurgery2021
A review on SARS-CoV-2 and stroke pathogenesis and outcome.
Review in The Egyptian journal of neurology, psychiatry and neurosurgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- COVID-19, neurovascular thrombotic problem and short summary on blood coagulation disorder: a brief review.The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Review
- Venous and arterial cerebral thrombosis: a COVID-19 dual pathology and single possible etiology-a case report.The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Article
- Outcome and characteristics of COVID-19 patients associated with stroke: a multicenter hospital-based study in Egypt.The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Article
- SARS-CoV-2 and monkeypox: what is common and what is not in a present pandemic versus a potential one-a neuropsychiatric narrative review.The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Review
- A case series of post COVID-19 mucormycosis-a neurological prospective.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021Article
- Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021Article
- Neurological sequelae of COVID-19: a review.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021Review
- Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases.The Egyptian journal of neurology, psychiatry and neurosurgery · 2021Review
- Bibliometric analysis of the worldwide scientific production on COVID-19 infection and cerebrovascular disease.Annals of cardiac anaesthesiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome corona virus 2 hit strongly and hardly the entire globe for more than 1 year with a morbidity exceeding 139 million and a mortality approaching 3 million worldwide since its emergence in China in December 2019 until April 2021. Although being termed after its ancestor the acute respiratory syndrome corona virus that emerged in 2002. Yet, the current corona virus has its unique devastating presentations being pulmonary and extra pulmonary. In the current review, a highlight on the role played by corona virus 2 on pathogenesis and outcome of stroke is presented with an attempt to point to the most approved ways through which the corona virus induce stroke being disturbance in renin angiotensin system and angiotensin-converting enzyme 2 receptors downregulation, endothelial cell damage with coagulopathy, cytokine storm, and platelet as well as outcome and risks in patients who are suffering stroke with modifiable vascular risk factors and catching the severe acute respiratory syndrome corona virus 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.